EE254 Budget Impact Analysis of Revumenib for the Treatment of Relapsed or Refractory Acute Leukemias With a KMT2A Translocation in the United States
Abstract
Authors
Ivo Abraham Pamela Martin Shailja Vaghela Timothy Klein Eric Chow Marie Rush Robert Morlock Huan Huang